{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"4.560","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"449,489,109","primaryexch":"香港交易所","ric":"6628.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMHT0W5","am":"24.35","iv":"","ew_strike":"","as":"4.090","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"4.080","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"0.500","shares_issued_date":"2025年9月17日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"錢雪明","underlying_ric":"6628.HK","hi52":"5.800","issuer_name":"創勝集團醫藥有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"4.040","mkt_cap":"1.83","f_aum_hkd":null,"ew_sub_per_to":"","ls":"4.080","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.520","aum":"","issued_shares_class_B":null,"vo":"5.81","secondary_listing_flag":false,"listing_date":"2021年9月29日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"創勝集團醫藥有限公司 - B","nm_s":"創勝集團－Ｂ","sym":"6628","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"創勝集團醫藥有限公司是一家從事臨床階段生物製藥的發現、研究、開發、製造和業務拓展的投資控股公司。該公司的產品包括MSB2311，TST001，TST005，TST002，TST004，TST003，TST008，MSB0254和TST006。該公司也提供合約開發和生產（CDMO）服務，主要包括製程開發服務、GMP/cGMP生產服務、細胞株開發服務、樣品檢測服務、配方優化服務及成藥性研究。","op":"4.560","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園1期<br/>19樓1928室","pc":"-11.30","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"4.600","isin":"KYG9005B1041","moneyness":""}},"qid":"1759074296544"}
